Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells.

Melzer C, Rehn V, Yang Y, Bähre H, von der Ohe J, Hass R.

Cancers (Basel). 2019 Jun 9;11(6). pii: E798. doi: 10.3390/cancers11060798.

2.

Changes in uPA, PAI-1, and TGF-β Production during Breast Cancer Cell Interaction with Human Mesenchymal Stroma/Stem-Like Cells (MSC).

Melzer C, von der Ohe J, Otterbein H, Ungefroren H, Hass R.

Int J Mol Sci. 2019 May 28;20(11). pii: E2630. doi: 10.3390/ijms20112630.

3.

Fiber optic plasmonic sensors: Providing sensitive biosensor platforms with minimal lab equipment.

Polley N, Basak S, Hass R, Pacholski C.

Biosens Bioelectron. 2019 May 1;132:368-374. doi: 10.1016/j.bios.2019.03.020. Epub 2019 Mar 12.

PMID:
30901726
4.

Involvement of Actin Cytoskeletal Components in Breast Cancer Cell Fusion with Human Mesenchymal Stroma/Stem-Like Cells.

Melzer C, von der Ohe J, Hass R.

Int J Mol Sci. 2019 Feb 18;20(4). pii: E876. doi: 10.3390/ijms20040876.

5.

In Vivo Cell Fusion between Mesenchymal Stroma/Stem-Like Cells and Breast Cancer Cells.

Melzer C, von der Ohe J, Hass R.

Cancers (Basel). 2019 Feb 5;11(2). pii: E185. doi: 10.3390/cancers11020185.

6.

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.

Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, Chen H, Papadakis AI, Auguste A, de Rink I, Kerkhoven RM, Bertos N, Gotlieb WH, Clarke BA, Leary A, Witcher M, Guiot MC, Pelletier J, Dostie J, Park M, Judkins AR, Hass R, Levine DA, Rak J, Vanderhyden B, Foulkes WD, Huang S.

Nat Commun. 2019 Feb 4;10(1):558. doi: 10.1038/s41467-018-06958-9.

7.

RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression.

Melzer C, Hass R, Lehnert H, Ungefroren H.

Cells. 2019 Jan 4;8(1). pii: E21. doi: 10.3390/cells8010021. Review.

8.

Use or Consequences: Probing the Cognitive Difference Between Two Measures of Divergent Thinking.

Hass RW, Beaty RE.

Front Psychol. 2018 Nov 27;9:2327. doi: 10.3389/fpsyg.2018.02327. eCollection 2018.

9.

MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells.

Melzer C, von der Ohe J, Hass R.

Cell Commun Signal. 2018 Oct 13;16(1):67. doi: 10.1186/s12964-018-0279-1.

10.

Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.

Wang Y, Chen SY, Colborne S, Lambert G, Shin CY, Santos ND, Orlando KA, Lang JD, Hendricks WPD, Bally MB, Karnezis AN, Hass R, Underhill TM, Morin GB, Trent JM, Weissman BE, Huntsman DG.

Mol Cancer Ther. 2018 Dec;17(12):2767-2779. doi: 10.1158/1535-7163.MCT-18-0348. Epub 2018 Sep 19.

PMID:
30232145
11.

On the Dependability and Feasibility of Layperson Ratings of Divergent Thinking.

Hass RW, Rivera M, Silvia PJ.

Front Psychol. 2018 Aug 13;9:1343. doi: 10.3389/fpsyg.2018.01343. eCollection 2018.

12.

Concise Review: Crosstalk of Mesenchymal Stroma/Stem-Like Cells with Cancer Cells Provides Therapeutic Potential.

Melzer C, von der Ohe J, Hass R.

Stem Cells. 2018 Jul;36(7):951-968. doi: 10.1002/stem.2829. Epub 2018 Apr 16. Review.

13.
14.

Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition.

Lang JD, Hendricks WPD, Orlando KA, Yin H, Kiefer J, Ramos P, Sharma R, Pirrotte P, Raupach EA, Sereduk C, Tang N, Liang WS, Washington M, Facista SJ, Zismann VL, Cousins EM, Major MB, Wang Y, Karnezis AN, Sekulic A, Hass R, Vanderhyden BC, Nair P, Weissman BE, Huntsman DG, Trent JM.

Clin Cancer Res. 2018 Apr 15;24(8):1932-1943. doi: 10.1158/1078-0432.CCR-17-1928. Epub 2018 Feb 9.

15.

Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC).

Melzer C, von der Ohe J, Hass R.

Cell Commun Signal. 2018 Jan 5;16(1):2. doi: 10.1186/s12964-018-0215-4.

16.

Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.

Melzer C, von der Ohe J, Hass R.

Biomed Res Int. 2017;2017:8534371. doi: 10.1155/2017/8534371. Epub 2017 Jul 12. Review.

17.

TGF-β-Dependent Growth Arrest and Cell Migration in Benign and Malignant Breast Epithelial Cells Are Antagonistically Controlled by Rac1 and Rac1b.

Melzer C, von der Ohe J, Hass R, Ungefroren H.

Int J Mol Sci. 2017 Jul 20;18(7). pii: E1574. doi: 10.3390/ijms18071574.

18.

Semantic search during divergent thinking.

Hass RW.

Cognition. 2017 Sep;166:344-357. doi: 10.1016/j.cognition.2017.05.039. Epub 2017 Jun 7.

PMID:
28601001
19.

The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma.

Melzer C, Hass R, von der Ohe J, Lehnert H, Ungefroren H.

Cell Commun Signal. 2017 May 12;15(1):19. doi: 10.1186/s12964-017-0175-0. Review.

20.

c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.

Hass R, Jennek S, Yang Y, Friedrich K.

Cell Commun Signal. 2017 Feb 17;15(1):10. doi: 10.1186/s12964-017-0165-2. Review.

21.

Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.

Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R.

Mol Cancer. 2017 Feb 1;16(1):28. doi: 10.1186/s12943-017-0595-x. Review.

22.

Sensitization of immune cells following hexylaminolevulinate photodynamic therapy of cervical intraepithelial neoplasia.

Hass R, Jacobs R, Kaufmann AM, Hillemanns P, Soergel P.

Photodiagnosis Photodyn Ther. 2017 Mar;17:82-86. doi: 10.1016/j.pdpdt.2016.11.006. Epub 2016 Nov 22.

PMID:
27888161
23.

Process analytical approaches for the coil-to-globule transition of poly(N-isopropylacrylamide) in a concentrated aqueous suspension.

Werner P, Münzberg M, Hass R, Reich O.

Anal Bioanal Chem. 2017 Jan;409(3):807-819. doi: 10.1007/s00216-016-0050-7. Epub 2016 Nov 9.

24.

Tracking the dynamics of divergent thinking via semantic distance: Analytic methods and theoretical implications.

Hass RW.

Mem Cognit. 2017 Feb;45(2):233-244. doi: 10.3758/s13421-016-0659-y.

PMID:
27752960
25.

SCCOHT tumors acquire chemoresistance and protection by interacting mesenchymal stroma/stem cells within the tumor microenvironment.

Otte A, Yang Y, von der Ohe J, Melzer C, Hillemanns P, Feuerhake F, Hass R.

Int J Oncol. 2016 Dec;49(6):2453-2463. doi: 10.3892/ijo.2016.3735. Epub 2016 Oct 14.

PMID:
27748897
26.

Limitations of turbidity process probes and formazine as their calibration standard.

Münzberg M, Hass R, Dinh Duc Khanh N, Reich O.

Anal Bioanal Chem. 2017 Jan;409(3):719-728. doi: 10.1007/s00216-016-9893-1. Epub 2016 Oct 1.

27.

Interaction of MSC with tumor cells.

Melzer C, Yang Y, Hass R.

Cell Commun Signal. 2016 Sep 8;14(1):20. doi: 10.1186/s12964-016-0143-0. Review.

28.

Comparison of in vitro-cultivation of human mesenchymal stroma/stem cells derived from bone marrow and umbilical cord.

Hoffmann A, Floerkemeier T, Melzer C, Hass R.

J Tissue Eng Regen Med. 2017 Sep;11(9):2565-2581. doi: 10.1002/term.2153. Epub 2016 Apr 28. Review.

PMID:
27125777
29.

Massive Clonal Selection and Transiently Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by Lentiviral RGB-Barcode Technology.

Selich A, Daudert J, Hass R, Philipp F, von Kaisenberg C, Paul G, Cornils K, Fehse B, Rittinghausen S, Schambach A, Rothe M.

Stem Cells Transl Med. 2016 May;5(5):591-601. doi: 10.5966/sctm.2015-0176. Epub 2016 Mar 31.

30.

Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells.

Yang Y, Melzer C, Bucan V, von der Ohe J, Otte A, Hass R.

Stem Cell Res Ther. 2016 Feb 11;7:28. doi: 10.1186/s13287-016-0289-0.

31.

c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.

Otte A, Rauprich F, von der Ohe J, Yang Y, Kommoss F, Feuerhake F, Hillemanns P, Hass R.

Oncotarget. 2015 Oct 13;6(31):31640-58. doi: 10.18632/oncotarget.5151.

32.

Acquisition of new tumor cell properties by MSC-derived exosomes.

Yang Y, Bucan V, Baehre H, von der Ohe J, Otte A, Hass R.

Int J Oncol. 2015 Jul;47(1):244-52. doi: 10.3892/ijo.2015.3001. Epub 2015 May 11.

PMID:
25963929
33.

Optical monitoring of chemical processes in turbid biogenic liquid dispersions by Photon Density Wave spectroscopy.

Hass R, Munzke D, Ruiz SV, Tippmann J, Reich O.

Anal Bioanal Chem. 2015 Apr;407(10):2791-802. doi: 10.1007/s00216-015-8513-9. Epub 2015 Mar 1.

PMID:
25725578
34.

Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells.

Chatterjee D, Marquardt N, Tufa DM, Hatlapatka T, Hass R, Kasper C, von Kaisenberg C, Schmidt RE, Jacobs R.

Front Immunol. 2014 Dec 29;5:662. doi: 10.3389/fimmu.2014.00662. eCollection 2014.

35.

Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines.

Yang Y, Otte A, Hass R.

Stem Cells Dev. 2015 May 15;24(10):1205-22. doi: 10.1089/scd.2014.0413. Epub 2015 Jan 26.

36.

Role of gamma-secretase in human umbilical-cord derived mesenchymal stem cell mediated suppression of NK cell cytotoxicity.

Chatterjee D, Marquardt N, Tufa DM, Beauclair G, Low HZ, Hatlapatka T, Hass R, Kasper C, von Kaisenberg C, Schmidt RE, Jacobs R.

Cell Commun Signal. 2014 Sep 30;12:63. doi: 10.1186/s12964-014-0063-9.

37.

In vitro and in vivo therapeutic approach for a small cell carcinoma of the ovary hypercalcaemic type using a SCCOHT-1 cellular model.

Otte A, Rauprich F, Hillemanns P, Park-Simon TW, von der Ohe J, Hass R.

Orphanet J Rare Dis. 2014 Aug 8;9:126. doi: 10.1186/s13023-014-0126-4.

38.

Interference of Ca²⁺ with the proliferation of SCCOHT-1 and ovarian adenocarcinoma cells.

Otte A, Rauprich F, von der Ohe J, Hillemanns P, Hass R.

Int J Oncol. 2014 Sep;45(3):1151-8. doi: 10.3892/ijo.2014.2518. Epub 2014 Jun 24.

PMID:
24969518
39.

Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells.

Chatterjee D, Tufa DM, Baehre H, Hass R, Schmidt RE, Jacobs R.

Blood. 2014 Jan 23;123(4):594-5. doi: 10.1182/blood-2013-09-524827. No abstract available.

40.

Detection of E6-AP as a potential therapeutic target in cervical specimen of HPV-infected women.

Hillemanns P, Jentschke M, Evans TG, Soergel P, Hass R.

Arch Gynecol Obstet. 2014 Jun;289(6):1281-6. doi: 10.1007/s00404-013-3120-5. Epub 2013 Dec 18.

PMID:
24346120
41.

Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome.

John K, Wielgosz S, Schulze-Osthoff K, Bantel H, Hass R.

Cell Death Dis. 2013 Oct 24;4:e886. doi: 10.1038/cddis.2013.408.

42.

Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo.

Mandel K, Yang Y, Schambach A, Glage S, Otte A, Hass R.

Stem Cells Dev. 2013 Dec 1;22(23):3114-27. doi: 10.1089/scd.2013.0249. Epub 2013 Sep 9.

PMID:
23895436
43.

Mesenchymal stem cells maintain long-term in vitro stemness during explant culture.

Otte A, Bucan V, Reimers K, Hass R.

Tissue Eng Part C Methods. 2013 Dec;19(12):937-48. doi: 10.1089/ten.TEC.2013.0007. Epub 2013 May 15.

PMID:
23560527
44.

Industrial applications of photon density wave spectroscopy for in-line particle sizing [Invited].

Hass R, Münzberg M, Bressel L, Reich O.

Appl Opt. 2013 Mar 1;52(7):1423-31. doi: 10.1364/AO.52.001423.

PMID:
23458794
45.

Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.

Mandel K, Seidl D, Rades D, Lehnert H, Gieseler F, Hass R, Ungefroren H.

PLoS One. 2013;8(2):e56591. doi: 10.1371/journal.pone.0056591. Epub 2013 Feb 14. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/e799099f-9509-4769-b761-853fccec4541.

46.
47.

LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells.

Bucan V, Mandel K, Bertram C, Lazaridis A, Reimers K, Park-Simon TW, Vogt PM, Hass R.

Genes Cells. 2012 Jul;17(7):559-67. doi: 10.1111/j.1365-2443.2012.01613.x. Epub 2012 Jun 12.

48.

Involvement of CD11b integrin in the alteration of metabolic factors after phorbol ester stimulation of human myeloid leukemia cells.

Mandel K, Otte A, Hass R.

Cell Commun Signal. 2012 Jul 11;10(1):13. doi: 10.1186/1478-811X-10-13.

49.

A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type.

Otte A, Göhring G, Steinemann D, Schlegelberger B, Groos S, Länger F, Kreipe HH, Schambach A, Neumann T, Hillemanns P, Park-Simon TW, Hass R.

Int J Oncol. 2012 Aug;41(2):765-75. doi: 10.3892/ijo.2012.1468. Epub 2012 May 8.

PMID:
22581215
50.

Effects of 50 Hz magnetic field exposure on the stress marker α-amylase in the rat mammary gland.

Fedrowitz M, Hass R, Löscher W.

Int J Radiat Biol. 2012 Jul;88(7):556-64. doi: 10.3109/09553002.2012.691614.

PMID:
22563858

Supplemental Content

Support Center